The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second malignancies in neuroblastoma patients: A report from the International Neuroblastoma Risk Group.
 
Mark A. Applebaum
No Relationships to Disclose
 
Tara O. Henderson
Other Relationship - Seagen
 
Wendy B. London
No Relationships to Disclose
 
Navin R. Pinto
No Relationships to Disclose
 
Samuel Louis Volchenboum
No Relationships to Disclose
 
Julie R. Park
No Relationships to Disclose
 
Arlene Naranjo
No Relationships to Disclose
 
Andrew DJ Pearson
No Relationships to Disclose
 
Barabara Hero
No Relationships to Disclose
 
Sharon Diskin
No Relationships to Disclose
 
Susan Lerner Cohn
Stock and Other Ownership Interests - Abbott Laboratories; Antares Pharmaceuticals; Array BioPharma; Array BioPharma (I); AstraZeneca; Auxilium; Avanir; Baxter; Bio-Reference Laboratories; Dentsply International Inc; Dyax; Edwards Lifesciences; Edwards Lifesciences (I); Gilead Sciences; Gilead Sciences (I); Hansen Medical; Jazz Pharmaceuticals; LabCorp; LabCorp (I); Mednax; Novavax; OPKO Health; Pfizer; Smith & Nephew; Techne Corp; United Therapeutics; United Therapeutics (I); Universal Health Services; Varian Medical Systems; Varian Medical Systems (I); Vermillion; Wuxi AppTec; Zimmer; Zogenix (I)
Research Funding - United Therapeutics (Inst)
Travel, Accommodations, Expenses - Novartis; United Therapeutics